We are live on ! Find out more
ALT icon

Altimmune
ALT

96 hedge funds and large institutions have $336M invested in Altimmune in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 36 increasing their positions, 20 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 20

56% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 16

46% more capital invested

Capital invested by funds: $231M → $336M (+$106M)

31% more call options, than puts

Call options by funds: $10.9M | Put options by funds: $8.33M

9% more funds holding

Funds holding: 88 → 96 (+8)

2.25% more ownership

Funds ownership: 61.81% → 64.06% (+2.2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
96
Holders Change
+8
Holders Change %
+9.09%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
36
Reduced
20
Closed
16
Calls
$10.9M
Puts
$8.33M
Net Calls
+$2.59M
Net Calls Change
+$4.09M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$47.6M
2
CCM
CAAS Capital Management
New York
+$17.9M
3
BBA
Baker Bros. Advisors
New York
+$14.1M
4
AC
Armistice Capital
New York
+$8.67M
5
Millennium Management
Millennium Management
New York
+$5.75M

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$21.2M
2
VA
VR Adviser
New York
-$16.2M
3
Invesco
Invesco
Georgia
-$4.73M
4
CS
Credit Suisse
Switzerland
-$4.52M
5
EP
Eversept Partners
New York
-$4.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
MS
76
Maven Securities
Jersey
$48K +$55.1K +3,408 New
SM
77
SG3 Management
Puerto Rico
$35K +$40.4K +2,500 New
BCV
78
Banque Cantonale Vaudoise
Switzerland
$21K +$24.3K +1,500 New
PCM
79
Penserra Capital Management
California
$11K +$1.37K +85 +11%
APA
80
American Portfolios Advisors
New York
$10.6K – – –
Carson Wealth (CWM LLC)
81
Carson Wealth (CWM LLC)
Nebraska
$10K – – –
PA
82
Parallel Advisors
California
$10K +$11.9K +734 New
CTC
83
Central Trust Company
Missouri
$7K +$8.08K +500 New
PNC Financial Services Group
84
PNC Financial Services Group
Pennsylvania
$5K – – –
CG
85
Cutler Group
California
$4K -$34.3K -2,120 -87%
APWA
86
Atlas Private Wealth Advisors
New Jersey
$4K – – –
TFA
87
Toth Financial Advisory
Virginia
$4K – – –
Royal Bank of Canada
88
Royal Bank of Canada
Ontario, Canada
$3K +$3.02K +187 New
CFGS
89
Concourse Financial Group Securities
Alabama
$3K +$3.23K +200 New
PAM
90
Panagora Asset Management
Massachusetts
$2K – – –
PCA
91
Providence Capital Advisors
North Carolina
$2K – – –
Daiwa Securities Group
92
Daiwa Securities Group
Japan
$1K – – –
Northwestern Mutual Wealth Management
93
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
SL
94
Savior LLC
Massachusetts
$1K +$631 +39 New
EP
95
Eversept Partners
New York
– -$4.29M -380,000 Closed
First Trust Advisors
96
First Trust Advisors
Illinois
– -$1.43M -127,085 Closed
PHP
97
Parkman Healthcare Partners
Connecticut
– -$1.13M -100,000 Closed
PAM
98
Premier Asset Management
Illinois
– -$627K -55,576 Closed
PC
99
PointState Capital
New York
– -$564K -50,000 Closed
GCP
100
GSA Capital Partners
United Kingdom
– -$484K -42,925 Closed
1 2 3
4
5

ALT Hedge Fund Activity: Q1 2021 in Review

96 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q1 2021, worth a combined $336M — up 46% from $231M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ALT positions and 16 closed out — a net gain of 9 holders — while 36 added to existing stakes and 20 trimmed.

The largest buyer was State Street, opening a new position worth an estimated $47.6M. The largest seller was UBS Group, cutting an estimated $21.2M.

  • 96 institutional investors held Altimmune (ALT) as of Q1 2021, up from 88 in Q4 2020.
  • Funds reported $336M of Altimmune stock for Q1 2021, up 46% quarter-over-quarter.
  • 25 funds opened new Altimmune positions in Q1 2021 and 16 closed out, a net change of +9 holders.
  • The largest Altimmune buyer in Q1 2021 was State Street, an estimated $47.6M added.
  • The largest Altimmune seller in Q1 2021 was UBS Group, an estimated $21.2M sold.

Based on aggregated 13F filings for Q1 2021.